I couldn't run the tests. Bash is blocked in this session's permission mode, so `python3 -m unittest discover` and `bash -n run.sh` were both refused. There are also no tests to run. No test files or `tests/` directory exist, and `refclass` appears only in the spec and the commit's note. I did the comparable checks by hand.

## What the commit contains

Commit `8f9caa8` adds one file, `docs/build/codex-1.md`, a status note saying phase 1 is blocked. It changes no code. Its factual claims match the repo:
- `knowledge/refclass-rules.md` and `knowledge/refclass-features.md` don't exist.
- There is no `deals/savara/out/report.md`.
- The comparables are at `deals/savara/out/biotech.md:129-132`.

## The four comparables, by hand

| Comparable | Pre-news close → day 1 → day 2 | Day 1 | Day 2 | Report says | Matches? |
|---|---|---:|---:|---:|---|
| Verona | 14.69 → 15.44 → 14.46 | +5.106% | −1.566% | −1.57% | Yes |
| KalVista | 11.98 → 15.06 → 14.95 | +25.710% | +24.791% | 24.79% | Yes |
| Crinetics | 35.89 → 45.91 → 43.51 | +27.919% | +21.231% | 21.23% | Yes |
| Liquidia | 15.56 → 15.35 → 15.60 | −1.350% | +0.257% | 0.26% | Yes |

- **Median of the three core comparables:** 21.231% (matches).
- **Median of all four:** (0.257 + 21.231) / 2 = 10.744% (matches).
- **Average of the two medians:** 15.988% (matches).
- **Event price:** $4.81 × 1.159879 = $5.579, which is **$5.58 to the cent**. The report rounds it to **$5.60**, so that line doesn't hold to the cent.

I checked only the arithmetic. I did not check the closing prices themselves against a price source.

## Problems and departures from the spec, most serious first

1. **None of phase 1 is delivered.** There is no refclass package, no `data/refclass.sqlite`, no quality gates, no new `run.sh` subcommands and no unit tests. All four acceptance tests at `docs/system-spec.md:192-195` are unmet, with the deadline on 13 November.
2. **Stopping everything was more than the blocker required.** The missing rules file does block the nested classes for `refclass show savara`. The features file is a phase 2 item, because tagging, likelihood ratios and rates come in phase 2. A lot needs neither file:
   - The phase 1 event filter is already set out in the spec at line 191 (approvals and CRLs since 2015, first products, companies under $3 billion).
   - Five things need no rules file at all: the eight quality gates, the run lock, the unit tests for odds form, Wilson intervals, abnormal returns and currency conversion (spec line 217), and the event and price tables.

   Spec line 213 asks for small steps, so these could have been built.
3. **The "to the cent" acceptance test conflicts with the rest of the spec.** The Savara figures are raw returns from ChartExchange closes. The engine is meant to use IBKR bars (spec line 55) and report abnormal returns against XBI (line 91). Matching to the cent would need the same unadjusted closes and a raw-return output. The note spots that XBI is missing but not the clash between data sources.
4. **Using the report's prices as test fixtures would prove nothing.** The note proposes copying the biotech report's prices into the tests. The engine would then "reproduce" numbers it was given, which tests the arithmetic but not the price pipeline the acceptance test is meant to check.
5. **The comparables use different announcement-timing conventions.** For Verona and Crinetics the pre-news close is on the announcement day, so the news came after the close. For KalVista and Liquidia it is the previous trading day. A fixed "close before the announcement date" rule would fail on two of the four. This ties to the spec's requirement to mark unknown announcement times (line 194), and the note doesn't raise it.
6. **Some claims in the note can't be confirmed.** "Searched ... backups" can't be checked. "`bash -n run.sh` passed" is plausible because the commit doesn't touch `run.sh`, but I couldn't re-run it.
7. **Housekeeping.** `docs/build/review-1.md` is untracked and appears empty.
8. **Minor defects in the spec itself.** The byline at line 3 reads "@Poop". The flow diagram at line 18 exported as a placeholder. Line 223 has a double space ("avoid  jargon").

**Verdict:** The block is honest and partly justified, but the commit delivers nothing from phase 1 and stops more work than the missing files actually block.
